Dec 09, 2021 / 06:35PM GMT
Brent Slava - Benzinga - Moderator
Ladies and gentlemen, coming up next, the chat is super hype about this next presentation and why not. Let's bring him on here. Here we have Bill Williams from BriaCell. Its ticker BCTX.
Bill, how you doing today?
Bill Williams - BriaCell Therapeutics Corp. - President & CEO
Doing great. It's great to join you at Bezinga here, Brent.
Brent Slava - Benzinga - Moderator
Yes. Like I said, the chat out in the YouTube land is absolutely excited for the presentation today. So I'll let you have at it, Bill. Take it away.
Bill Williams - BriaCell Therapeutics Corp. - President & CEO
Great. Thanks so much. Of course, we have forward-looking statements in here. Just a brief snapshot of our cap structure. We are a preclinical -- not preclinical, pre-revenue company in biotech. So a little bit different than what you were just looking at for urban-gro. But share price around $9; shares outstanding, 15.5 million or so, market cap about
Briacell Therapeutics Corp at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers